Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-19-000632
Filing Date
2019-05-30
Accepted
2019-05-30 15:45:41
Documents
2
Period of Report
2019-05-29

Document Format Files

Seq Description Document Type Size
1 form4a-05302019_120527.html 4/A  
1 form4a-05302019_120527.xml 4/A 4568
2 ex24-05302019_120528.htm EX-24 6596
  Complete submission text file 0001415889-19-000632.txt   12817
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Reporting) CIK: 0001609805 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31326 | Film No.: 19866378